AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00802204 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: PET scan
Description: Both lean and obese undergo a PET scan of the brain using the radioligand,fallypride \[18F\] at baseline. Obese subjects who complete caloric restriction will have repeat scan after diet.~Completed at baseline and post-VLCD
Study NCT00802204 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: PET scan
Description: Both lean and obese undergo a PET scan of the brain using the radioligand,fallypride \[18F\] at baseline. Obese subjects who complete caloric restriction will have repeat scan after diet.~Completed at baseline and post-VLCD
Study NCT00802204 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Oral glucose tolerance test
Description: Subjects will be required to drink a glucose solution; blood samples will be taken over a 5-hour time period Completed at baseline by both lean and obese and in obese post-VLCD
Study NCT00802204 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test
Description: Subjects will be required to drink a glucose solution; blood samples will be taken over a 5-hour time period Completed at baseline by both lean and obese and in obese post-VLCD
Study NCT00802204 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: MRI
Description: An MRI of the brain and abdomen will be performed prior to PET scan One time at baseline in both lean and obese
Study NCT00802204 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MRI
Description: An MRI of the brain and abdomen will be performed prior to PET scan One time at baseline in both lean and obese
Study NCT00802204 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychological scales to assess attitudes and behaviors related to eating and quality of life
Description: A series of short psychological scales will be administered during the study. Completed at baseline
Study NCT00802204 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychological scales to assess attitudes and behaviors related to eating and quality of life
Description: A series of short psychological scales will be administered during the study. Completed at baseline
Study NCT00802204 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Caloric Restriction
Description: Obese participants only complete a short-term (\~10days) very low calorie diet
Study NCT05103878 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BT051 100mg
Description: Single oral dose of 100mg BT051
Study NCT05103878 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BT051 300mg
Description: Single oral dose of 300mg BT051
Study NCT05103878 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BT051 700mg
Description: Single oral dose of 700mg BT051
Study NCT05103878 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BT051 1500mg
Description: Single oral dose of 1500mg BT051
Study NCT05103878 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BT051 3500mg
Description: Single oral dose of 3500mg BT051
Study NCT05103878 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching Placebo
Description: Placebo Matching BT051
Study NCT02701387 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Megagen AnyRidge dental implant
Description: AnyRidge is an approved dental implant with a knife edge, thin thread design available in various thread widths (depth).
Study NCT02701387 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Megagen EZ Plus dental implant
Description: EZ Plus is an approved dental implant with a standard thread design (width and depth) and that is comparable to many other dental implants currently available on the market.
Study NCT02495155 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PROSPECT
Description: PROSPECT is an internet-based exercise and behavioral symptom management program developed for patients who experience long-term side effects from cancer treatment. The cancer-specific symptom management intervention is intended as a self-management adjunct to improve cancer- and treatment-related symptoms through non-pharmacologic approaches.
Study NCT02130739 — intervention group
Intervention type: PROCEDURE
Intervention: thoracic epidural anesthesia
Description: thoracic epidural anesthesia following continuous thoracic epidural analgesia for mastectomy
Study NCT02130739 — intervention group
Intervention type: PROCEDURE
Intervention: mastectomy
Description: mastectomy with/without breast reconstruction
Study NCT02130739 — intervention group
Intervention type: DRUG
Intervention: Ropivacaine
Description: Thoracic epidural anesthesia performed using 0.375% or 0.5% ropivacaine
Study NCT02130739 — intervention group
Intervention type: DRUG
Intervention: Propofol
Description: Thoracic epidural anesthesia performed followed by sedation consisting of propofol
Study NCT02130739 — intervention group
Intervention type: DRUG
Intervention: Fentanyl
Description: thoracic epidural analgesia continued; supplemented by a continuous epidural infusion of ropivacaine 0.15%, 2 ml/h with fentanyl 8mcg/h.
Study NCT03071614 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: News items with spin
Description: Interpretation of news items with spin
Study NCT03071614 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: News items without spin
Description: Interpretation of news items without spin
Study NCT04097613 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Povidone-Iodine
Description: Povidone Iodine solution 5% (0.5% available iodine) by 3MTM has been specially formulated as a nasal antiseptic. They have shown topical application to be clinically safe, tolerable and to be rapidly bacteriocidal against aerobic gram positive and gram- negative bacteria including methicillin resistant Staphylococcus aureus, methicillin resistant Staphylococcus epidermidis, vancomycin resistant Enterococcus faecium and Enterococcus faecalis (VRE) and yeast (3M study 05-011100,05-011017, 05-011322).
Study NCT04097613 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesonide
Description: Budesonide is is provided in nebules (1mg/2cc). Patients will place two nebules of budesonide into the 250mls of saline.
Study NCT03988530 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Scopolamine
Description: Subjects will self-administer DPI-386 Nasal Gel (0.2 mg / 0.12 g) or placebo nasal gel (0.12 g) on Treatment Day 1, and on Treatment Days 2 -4 all subjects will self administer DPI-386 Nasal Gel (0.2 mg / 0.12 g).
Study NCT03988530 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Nasal Gel
Description: Placebo Nasal Gel (0.12g) twice a day on Treatment Day 1.
Study NCT03871322 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D and K2 supplementation
Description: if supplementation of vitamin D and K2 changes the time to fracture healing
Study NCT03871322 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D supplementation
Description: if supplementation of vitamin D alone changes the time to fracture healing
Study NCT03871322 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo control group
Study NCT01666509 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rossoseq™
Study NCT01666509 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02963545 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care patients in neurology department
Description: patients characteristics, history, clinical signs chronology and usual medical care by the emergency units, cerebral infarction area
Study NCT02963545 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: blood and urines sampling
Description: Collection samples for biochemical determinations of serotonin pathway and kynurenine pathway parameters determinations
Study NCT02963545 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: blood and urines sampling
Description: Collection samples for biochemical determinations of serotonin pathway and kynurenine pathway parameters determinations
Study NCT02963545 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Psychiatric evaluation
Description: depression scale, impulsivity scale, hostility scale , tobacco consumption questioning
Study NCT04170803 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dry Needling
Description: The participant will undergo true or sham dry needling treatment with simultaneous monitoring using the NIRS head cap.
Study NCT04170803 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Dry Needling
Description: The participant randomized to the sham group will undergo placebo dry needling which is functionally mimicking trigger point dry needling
Study NCT03926975 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Scleral Lens
Description: The contact lens will be worn on one eye.
Study NCT03926975 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No lens
Description: No lens worn on the contralateral control eye
Study NCT02317211 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Anthocyanin
Description: Extract of blueberry and huckleberry （MEDOX，http://www.medox.no/english）
Study NCT02317211 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: starch
Study NCT03836495 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: lysine and phosphorus
Description: addition of lysine and essential amino acid and/or phosphorus an essential mineral
Study NCT01362361 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFOX6 + BIBF 1120
Description: mFOLFOX6 + BIBF1120 (2x200 mg/d d1-d14) (repeated every 14 days)
Study NCT01362361 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: mFOLFOX6+placebo
Description: mFOLFOX6 + placebo (2x200 mg/d d1-d14) (repeated every 14 days)
Study NCT02829242 — intervention group
Intervention type: DEVICE
Intervention: NIRS Monitoring (SenSmart Monitor)
Study NCT01003210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyland's earache drops
Description: 3-4 drops in affected ear 3 times a day as needed for up to 5 days
Study NCT04666779 — intervention group
Intervention type: OTHER
Intervention: Chiropractic care
Description: Care provided by chiropractors, based on manual therapy, exercise prescription and patient advice/education/reassurance
Study NCT03269370 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Anchors Away
Description: Modular Cognitive Behavioral Therapy delivered through a mobile app.
Study NCT03269370 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Enhanced Anchors Away
Description: Modular Cognitive Behavioral Therapy delivered through a mobile app. Extra modules will focus specifically on parenting skills relevant to having an anxious child.
Study NCT03269370 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-Help E-Book
Description: Parents will read Helping Your Anxious Child: A Step-by-Step Guide (Rapee, Wignall, Spence, Lyneham, \& Cobham, 2008)
Study NCT00573209 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Far Infrared Radiation
Description: Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each session.
Study NCT00396201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF Plus Plerixafor
Description: Randomized participants underwent mobilization with G-CSF 10 µg/kg/day for 4 days, administered by subcutaneous injection (SC) injection. On the evening of Day 4, participants received a dose of plerixafor 240 µg/kg, administered by SC injection. On Day 5, participants returned to the clinic and received a morning dose of G-CSF 10 µg/kg and underwent apheresis approximately 10 to 11 hours after the dose of plerixafor (within 60 minutes after administration of G-CSF). Participants continued to receive an evening dose of plerixafor followed the next day by a morning dose of G-CSF and apheresis for up to a maximum of 4 aphereses or until ≥ 5\*10\^6 CD34+ cells/kg were collected.
Study NCT00904800 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0837
Description: tablet, oral, once daily, 1+5 days
Study NCT00904800 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT02971631 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exendin 9-39
Description: Complete blockade of action of endogenous GLP-1 by Exendin 9-39. Defined as a physiological study, not a clinical trial as such (as advised by the UK MHRA).
Study NCT02971631 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Infusion of 1% human albumin in normal saline
Study NCT01128127 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group education, audit-feedback and computer support
Description: Psycho-educational group workshop: two theory-practice sessions on both evidence-based guidelines on PPI-NSAID prescription and communication and negotiation skills to deal with patients. All participants will fill out an initial questionnaire concerning prescribing patterns and barriers to appropriate prescription. All attendees will be given a reminder printed material designed to give the necessary information in a brief fashion and for maximal visual impact.~Audit-Feedback: participants will receive, monthly and by e-mail, an individualized report with data of their own appropriate/inappropriate PPI prescriptions and avoidable costs.~CCDSS: interactive computer program designed to assist physicians with decision making when prescribing PPI associated to NSAID. It consists in pop-up alert screens that aim to influence prescription choice according to each patient characteristics and evidence-based clinical guidelines.
Study NCT01128127 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Audit-feedback and computer support
Description: Audit-Feedback: participants will receive, monthly and by e-mail, an individualized report with data of their own appropriate/inappropriate PPI prescriptions and avoidable costs~CCDSS: interactive computer program designed to assist physicians with decision making when prescribing PPI associated to NSAID. It consists in pop-up alert screens that aim to influence prescription choice according to each patient characteristics and evidence-based clinical guidelines.
Study NCT01128127 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Usual intervention includes:~Compulsory attendance both to courses (10-12 hours) and to short sessions (around 30 min.) on the rational use of drugs held in groups and during working hours. Each primary care physician attends to 1-2 courses and 3-4 short sessions per year.~Every three months, physicians receive a feedback paper with information on his/her own prescribing overall costs comparing to his/her primary care center average cost.~Distribution of a printed booklet of recommendations, delivered personally or through mass mailings, on the prescribing of PPI-NSAID.
Study NCT01378234 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Discharge Planning Program transitional care
Description: Enhanced Discharge Planning Program (EDPP) provides telephonic short-term post-discharge social work services that assess and intervene from a biopsychosocial perspective for at-risk older adults returning home after an inpatient hospitalization. EDPP follows a four-step process to with three guiding tasks to reach the goal of preventing avoidable adverse events post-discharge:~1. Ensure patients understand the discharge plan of care and receive recommended services while screening for unidentified medical or social needs~2. Connect patients to outpatient health services (ex: home health, in-home services, dialysis, radiology, laboratory services, specialty care) with particular emphasis on the first physician follow-up appointment~3. Supporting caregivers to reduce stress and burden
Study NCT01143727 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Santyl
Description: Apply one 24-hr period sufficient to cover the wound.
Study NCT01143727 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tegaderm Hydrogel
Description: Apply once 24-hr period sufficient to cover the wound.
Study NCT04207450 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo gel
Description: Placebo gel application followed by placebo solution application (distilled water)
Study NCT04207450 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo Gel + 5% Glutaraldehyde Aqueous Solution
Description: Placebo gel followed by 5% aqueous glutaraldehyde solution
Study NCT04207450 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Phosphoric Acid 37% + Solução aquosa de glutaraldeído a 5%
Description: 37% phosphoric acid application followed by 5% aqueous glutaraldehyde solution
Study NCT04086004 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group I Experimental Motor Imagery
Description: The experimental group will receive dual task balance training for 30 minutes/day with additional mental imagery for 10 minutes/day, three days/week, for a period of eight weeks
Study NCT04086004 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dual task training
Description: group will receive dual task balance training for 40 minutes for three days/ week for eight weeks
Study NCT02681679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.1% bromfenac ophthalmic solution
Study NCT02681679 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: femtosecond laser cataract surgery
Study NCT02681679 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: femtosecond laser cataract surgery
Study NCT01792804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trimethoprim-Sulfamethoxazole
Description: study drug 1
Study NCT01792804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clindamycin
Description: study drug 2
Study NCT01792804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linezolid
Description: study drug 3
Study NCT01792804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flucloxacillin
Description: study drug 4
Study NCT01792804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cloxacillin
Description: study drug 5
Study NCT01792804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vancomycin
Description: study drug 6
Study NCT01792804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daptomycin
Description: study drug 7
Study NCT01792804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cefazolin
Description: study drug 8
Study NCT01330134 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lidocaine
Description: 2ml 1% lidocaine placed onto surface of the skin immediately prior to 1% lidocaine subcutaneous injection
Study NCT01330134 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: lidocaine
Description: 1% lidocaine subcutaneous injection alone
Study NCT03919279 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active tVNS
Description: tVNS using TENS device from Schwa-Medico (TENSeco2) + auricular electrode applied on the left ear (Schwa-Medico) + conductive gel class I; 25 Hz stimulation 1 hour daily for 1 month
Study NCT04286087 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: neck incisions closed at bedside at the time of drain removal under local anesthesia
Description: Participants allocated to the investigational group will have neck incisions closed at bedside at the time of drain removal under local anesthesia
Study NCT04286087 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: standard treatment
Description: Participants in the control group will have standard treatment performed as per current practice,their incision will be left to close by secondary intention
Study NCT01606267 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: health systems intervention: HEP+ICCM
Description: In the HEP+ICCM intervention areas, HEWs will assess and treat childhood pneumonia with cotrimoxazole. The program will strengthen the capacity of HEWs to assess, classify and treat malaria (with ACTs), diarrhea (with ORS) and undernutrition (with therapeutic feeding) through refresher trainings and strengthening supervision, logistical support and the ICCM system overall.
Study NCT00574145 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bio-field energy therapy
Description: Practitioner's hands to influence the human energy field surrounding the patient's body.
Study NCT00574145 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: fatigue assessment and management
Description: duration
Study NCT00574145 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: fatigue assessment and management
Description: duration
Study NCT00574145 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: psychosocial assessment and care
Description: duration
Study NCT00574145 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: psychosocial assessment and care
Description: duration
Study NCT00574145 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: quality-of-life assessment
Description: duration
Study NCT00574145 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: quality-of-life assessment
Description: duration
Study NCT00574145 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: therapeutic touch
Description: Practitioner's hands to influence the human energy field surrounding the patient's body